Janney Montgomery Scott LLC Bluebird Bio, Inc. Transaction History

Janney Montgomery Scott LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 26, 2021	SELL	$18.04 - $22.09 $148,000 - $181,226	-8,204 Closed	0 $0
Q1 2021 Apr 27, 2021	BUY	$16.59 - $33.89 $136,104 - $278,033	8,204 New	8,204 $247,000
Q4 2020 Jan 25, 2021	SELL	$27.5 - $37.92 $302,720 - $417,423	-11,008 Closed	0 $0
Q3 2020 Nov 06, 2020	BUY	$34.44 - $43.75 $162,040 - $205,843	4,705 Added 74.65%	11,008 $594,000
Q2 2020 Jul 23, 2020	BUY	$27.12 - $45.97 $170,937 - $289,748	6,303 New	6,303 $385,000

151

63.4M

264K

428K

Ticker BLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,121,800
Market Cap $28.5M
Description
bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

Stay updated on Janney Montgomery Scott LLC with notifications on news.